- 全部删除
- 您的购物车当前为空
α-Glucosidase-IN-32 (compound f26),是一种口服有效的α-glucosidase抑制剂,具有可逆、非竞争性特点,IC50值为3.07 μM。该化合物通过与α-glucosidase形成氢键和疏水相互作用,以改变其构象和二级结构,从而抑制酶活性。α-Glucosidase-IN-32 主要用于糖尿病研究。
α-Glucosidase-IN-32 (compound f26),是一种口服有效的α-glucosidase抑制剂,具有可逆、非竞争性特点,IC50值为3.07 μM。该化合物通过与α-glucosidase形成氢键和疏水相互作用,以改变其构象和二级结构,从而抑制酶活性。α-Glucosidase-IN-32 主要用于糖尿病研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
产品描述 | α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive inhibitor of α-glucosidase that is orally active and exhibits an IC50 of 3.07 μM. It forms a complex with α-glucosidase via hydrogen bonding and hydrophobic interactions, inducing conformational and secondary structure changes in the enzyme, thereby inhibiting its activity. This compound is utilized in diabetic disease research [1]. |
分子量 | 510.61 |
分子式 | C32H22N4OS |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容